ACME Laboratories Ltd ACMELAB
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 6.22
- Price/Sales
- 0.51
- Dividend Yield (Trailing)
- 4.89%
- Dividend Yield (Forward)
- 4.89%
- Total Yield
- 4.89%
Company Profile
ACME Laboratories Ltd is engaged in the manufacturing, marketing, and distribution of generic pharmaceutical products in Bangladesh. The company offers pharmaceutical, ayurvedic, herbal, nutraceutical products, and veterinary products. It produces various forms of dosage including tablet, capsule, dry syrup, cream, ointment, powder and injection among others.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 8,816
- Website
- https://www.acmeglobal.com
Comparables
Valuation
|
Metric
|
ACMELAB
|
RENATA
|
ORIONPHARM
|
|---|---|---|---|
Price/Earnings (Normalized) | 6.22 | 43.50 | 31.53 |
Price/Book Value | 0.61 | 2.83 | 0.72 |
Price/Sales | 0.51 | 2.52 | 1.29 |
Price/Cash Flow | — | 42.34 | 14.77 |
Price/Earnings
ACMELAB
RENATA
ORIONPHARM
Financial Strength
|
Metric
|
ACMELAB
|
RENATA
|
ORIONPHARM
|
|---|---|---|---|
Quick Ratio | 0.25 | 0.39 | 1.23 |
Current Ratio | 1.13 | 1.27 | 1.51 |
Interest Coverage | 2.78 | 3.64 | 8.90 |
Quick Ratio
ACMELAB
RENATA
ORIONPHARM
Profitability
|
Metric
|
ACMELAB
|
RENATA
|
ORIONPHARM
|
|---|---|---|---|
Return on Assets (Normalized) | 4.83% | 3.98% | 0.91% |
Return on Equity (Normalized) | 10.22% | 6.35% | 2.35% |
Return on Invested Capital (Normalized) | 8.63% | 6.17% | 1.24% |
Return on Assets
ACMELAB
RENATA
ORIONPHARM
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Zkfcfzpn | Wwxbnb | $69.8 Bil | |
ZTS
| Zoetis Inc Class A | Xwfqzbvlt | Gzyk | $68.9 Bil | |
HLN
| Haleon PLC ADR | Fqgxnng | Qfgfk | $37.7 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Mqgkjwnq | Hjzj | $14.8 Bil | |
VTRS
| Viatris Inc | Mhdvhqfct | Kpfq | $13.6 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Snmrwtwpw | Bfrg | $11.9 Bil | |
CTLT
| Catalent Inc | Jgfqvty | Jggvrx | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Yhmfwwj | Kpqf | $4.2 Bil | |
CURLF
| Curaleaf Holdings Inc | Jdqbydl | Xvyq | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Bwsvsfvr | Vcgry | $3.5 Bil |